Crossmark

Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9/2

Crossref DOI link: https://doi.org/10.1186/s12974-018-1182-9

Published Online: 2018-06-21

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pan, Cailong

Wang, Chaoyu

Zhang, Li

Song, Ling

Chen, Yuan

Liu, Bingqian

Liu, Wen-Tao

Hu, Liang

Pan, Yinbing
Funding

Funding for this research was provided by:

National Science Foundation for Young Scientists of Jiangsu province (KY1010831161312010)

National Natural Science Foundation of China (Nos. 81471142)

Key project of science and technology development foundation of Nanjing Medical University (2015NJMUZD054)
License Information

Text and Data Mining valid from 2018-06-21
More Information

Article History

Received: 23 January 2018

Accepted: 29 April 2018

First Online: 21 June 2018

Ethics approval and consent to participate

: All procedures were strictly performed in accordance with the regulations of the ethics committee of the International Association for the Study of Pain and the Guide for the Care and Use of Laboratory Animals (The Ministry of Science and Technology of China, 2006). All animal experiments were approved by Nanjing Medical University Animal Care and Use Committee and were designed to minimize suffering and the number of animals used.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.